You cannot create a Lecturio account without granting permission to use your email address.
Based on our terms and conditions it is not possible to create a Lecturio account without an email address. Lecturio requires a valid email address in order to inform you about important changes and updates (e.g., of our terms and conditions, the status of your course access, etc.).
Antibiotic Resistance Profiles in the Democratic Republic of Congo (DRC)
Share
Antibiotic Resistance Profiles in the Democratic Republic of Congo (DRC)
by Jean-Jacques Muyembe-Tamfum, MD, PhD
Antibiotic Resistance Profiles in DRC examines the specific patterns of antimicrobial resistance found in key bacterial pathogens within the Democratic Republic of Congo, providing essential epidemiological knowledge for healthcare providers working in this region. This specialized course addresses the critical challenge of antibiotic resistance in resource-limited settings, where limited diagnostic capabilities and varying drug availability create unique therapeutic challenges. Understanding regional resistance patterns is fundamental for medical practitioners, as inappropriate antibiotic selection based on global or Western resistance data can lead to treatment failures, increased morbidity and mortality, and further propagation of resistant organisms in vulnerable populations.
Prior knowledge of basic microbiology, infectious diseases, and pharmacology principles is essential for comprehending the complex relationships between bacterial pathogens and antimicrobial agents. The clinical relevance of this course extends directly to everyday medical practice in the DRC and similar settings, where empirical antibiotic therapy must be guided by local resistance data rather than international guidelines. Healthcare professionals equipped with knowledge of regional resistance profiles can make more informed treatment decisions, optimize limited antibiotic resources, and contribute to antimicrobial stewardship efforts that help preserve the effectiveness of available drugs. This understanding is particularly crucial for managing endemic diseases and common bacterial infections, where knowledge of local resistance patterns can mean the difference between successful treatment and therapeutic failure.
Your Educators of course Antibiotic Resistance Profiles in the Democratic Republic of Congo (DRC)
Jean-Jacques Muyembe-Tamfum, MD, PhD
Dr. Jean-Jacques Muyembe-Tamfum is the Director-General of the Institut National de Recherche Biomédicale (INRB) in Kinshasa, Democratic Republic of the Congo. He obtained his Medical Degree from the University of Lovanium (now University of Kinshasa) in 1969, and his Ph.D. in Virology from the University of Leuven, Belgium, in 1973.
In 1976, Dr. Muyembe investigated the first Ebola outbreak in Congo and draw the blood samples to discover a new virus. He led the research for Ansuvimab which has been successfully tested as a treatment for Ebola and approved for use in 2019. Owing to his achievements in Ebola research and outbreak response, he received the Royal Society Africa Prize in 2014 and the Hideyo Noguchi Africa Prize in 2019.
Within Lecturio, Dr. Muyembe-Tamfum shares his knowledge of infectious diseases, specifically Ebola and Mpox.
User reviews
(1)
5,0 of 5 stars
5 Stars
5
4 Stars
0
3 Stars
0
2 Stars
0
1 Star
0
User reviews
(1)
5,0 of 5 stars
5 Stars
5
4 Stars
0
3 Stars
0
2 Stars
0
1 Star
0
Get Premium to add bookmarks
Lecturio Premium gives you full access to all content and features.